Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 93.37 K219.07 K138.1 K — Research & development ——— — Operating income -93.37 K-219.07 K-138.1 K — Non-Operating Income, Total 230.7 K5.31 M4.95 M — Interest expense, net of interest capitalized 100 K100 K100 K — Non-Operating Income, excl. Interest Expenses 15.35 K2.55 M2.38 M — Unusual income/expense 115.35 K2.65 M2.48 M — Pretax income 137.33 K5.09 M4.82 M — Equity in earnings ——— — Taxes ——— — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 21.98 K2.43 M2.34 M — Discontinued operations ——— — Net income 21.98 K2.43 M2.34 M — Dilution adjustment —2.64 M— — Preferred dividends —2.64 M— — Diluted net income available to common stockholders 21.98 K2.43 M2.34 M — Basic earnings per share (Basic EPS) 00.320.32 — Diluted earnings per share (Diluted EPS) 00.320.37 — Average basic shares outstanding 14.05 M29.57 M38.06 M — Diluted shares outstanding 14.05 M35.58 M38.44 M — EBITDA ——— — EBIT ——— — Cost of revenue ——— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) ——— —